Actively Recruiting
TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors
Led by Tarapeutics Science Inc. · Updated on 2024-05-14
26
Participants Needed
1
Research Sites
140 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A phase 1 dose escalation and expanded cohort study of TR115 in the treatment of adult patients with relapsed/refractory non-hodgkin's lymphoma or advanced solid tumors.
CONDITIONS
Official Title
TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Understand and agree to participate with signed informed consent
- Male or female aged 18 years or older
- Diagnosed with relapsed/refractory non-Hodgkin's lymphoma having received at least one prior systemic therapy or advanced solid tumors with no suitable standard treatment
- Eastern Cooperative Oncology Group performance status of 2 or less at screening
- Life expectancy of at least 3 months
- Acceptable organ function including specific blood counts and liver and kidney tests within defined limits
- Agree to use medically approved contraceptives during the study and for 6 months after the last dose
You will not qualify if you...
- Known or suspected allergy to the investigational drug components
- Medical or surgical history that excludes participation per protocol
- Previous medical treatments that exclude participation per protocol
- Abnormal laboratory test results excluding participation
- Pregnant or breastfeeding women or less than six months postpartum if not breastfeeding
- Unable to complete the study due to poor compliance or other reasons, or deemed unsuitable by investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The first affiliated hospital, Zhejiang university school of medicine
Hangzhou, Zhejiang, China, 310003
Actively Recruiting
Research Team
Y
Yang Shu, MD, BS.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here